Caffeine Completed Phase 2 Trials for Retinopathy of Prematurity Prevention

IndicationsStatusPurposePhase
CompletedPrevention2
clinicaltrials.gov IdentifierTitleDrugs
NCT02344225Synergistic Pharmacologic Intervention for Prevention of ROP (SPIPROP Study)